Pfizer in $5 billion accelerated buyback deal with Goldman, Sachs & Co

Mon Feb 9, 2015 6:00pm EST
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

(Reuters) - Drugmaker Pfizer Inc (PFE.N: Quote) said it entered into an agreement with Goldman, Sachs & Co to buy back $5 billion of its stock.

Pfizer said the accelerated share repurchase was assumed in the forecast for the full year it provided last month.

Under the agreement, which forms a part of Pfizer's existing buyback authorization, about 150 million shares will be bought.

The settlement is expected during or prior to the third quarter.

Shares of the New York-based company closed at $33.06 on the New York Stock Exchange on Monday.

(Reporting by Anjali Rao Koppala in Bengaluru; Editing by Joyjeet Das)

 
A man walks past Pfizer's world headquarters in New York in this file photo from April 28, 2014. REUTERS/Andrew Kelly/Files